Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119287) titled 'Cryoablation followed by adebrelimab and chemotherapy for oligoprogressive NSCLC after first-line immunotherapy: A single-center, single-arm, phase II clinical study' on Feb. 25.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
Condition:
Non-small cell lung cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-01
Target Sample Size: Experimental group:38;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj...